Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00634270 |
|---|---|
| Brief Title: | A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas (Protocol 102) |
| First Submitted : | February 20, 2008 |
| First Submitted that Met QC Criteria : | March 12, 2008 |
| First Posted : | March 13, 2008 (Estimate) |
| Results First Submitted : | July 3, 2015 |
| Results First Submitted that Met QC Criteria : | December 21, 2016 |
| Results First Posted : | February 14, 2017 |
| Last Update Submitted that Met QC Criteria : | October 12, 2017 |
| Last Update Posted : | November 17, 2017 |